BioSpace News Archive

Independent corporate cannabis retailer Fire & Flower is pleased to announce that it has entered into binding agreement to acquire all of the issued and outstanding shares of 10945072 Canada Inc

Berkeley Research Group (BRG) announced today that Orlando L. Alvarez Jr. has joined the firm as a managing director in its Healthcare Performance Improvement

Eiger BioPharmaceuticals, Inc. today announced Phase 2 ULTRA study results in primary and secondary lymphedema of the lower limb demonstrated no improvement of ubenimex over placebo in the primary endpoint of skin thickness and secondary endpoints of limb volume and bioimpedance. No safety signals attributed to ubenimex were identified.

Diplomat Pharmacy, Inc. will release its third-quarter 2018 operating results after market close Tuesday, Nov. 6, with a conference call to follow at 5 p.m. ET.

AmpliPhi Biosciences Corporation today announced the closing of its previously announced underwritten public offering.

Casting messages widely throughout an electronic health record instead of using more focused direct messaging in diabetes care leads to more hospital visits and higher medical costs, according to a study published in the current issue of The American Journal of Managed Care®.

Collaboration that will streamline researchers’ access to biological insights by combining Nashville Biosciences’ BioVU® biobank with GENEWIZ’s next generation sequencing.

Boston Scientific Corporation today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed and commercialized the SpaceOAR® Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer.

Results of the Azeliragon Phase 3 STEADFAST Trial to be Presented during Oral Session

Mobile medical clinics to provide disability exams to veterans in rural and underserved areas